DCM
ALBO

Dupont Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Dupont Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,488
Closed -$229K – 1935
2021
Q1 		$229K Sell
6,488
-1,331
-17% -$49.1K 0.01% 1245
2020
Q4 		$293K Sell
7,819
-584
-7% -$21.2K 0.01% 1040
2020
Q3 		$280K Sell
8,403
-563
-6% -$16.4K 0.01% 1001
2020
Q2 		$238K Buy
+8,966
New +$211K 0.01% 1067

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dupont Capital Management's ALBO Position: Q2 2021 in Review

Dupont Capital Management sold out of Albireo Pharma Inc (ALBO) in Q2 2021, closing a stake of 6,488 shares — an estimated $229K sold.

Dupont Capital Management first reported a position in ALBO in Q2 2020 and held it in 4 quarters. The position peaked at $293K in Q4 2020. 99 funds tracked by Wall St. Rank hold ALBO as of Q2 2021.

  • Dupont Capital Management reported no remaining Albireo Pharma Inc position as of Q2 2021 after selling out during the quarter.
  • Dupont Capital Management sold 6,488 Albireo Pharma Inc shares in Q2 2021, an estimated $229K.
  • Dupont Capital Management first reported a position in Albireo Pharma Inc in Q2 2020 and held it in 4 quarters.
  • Dupont Capital Management's Albireo Pharma Inc position peaked at $293K in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2021.

Based on Dupont Capital Management's 13F filing for Q2 2021, filed 30 Jul 2021.